Related Experiment Video
Updated: Aug 9, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
The Propagation and Quantification of Two Emerging Oncolytic Viruses: Vesicular Stomatitis (VSV) and Zika (ZIKV)
Robert E Means1, Sounak Ghosh Roy1, Samuel G Katz2
1Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
Abstract:
Developments in genetic engineering have allowed researchers and clinicians to begin harnessing viruses to target and kill cancer cells, either through direct lysis or through recruitment of antiviral immune responses. Two powerful viruses in the fight against cancer are the single-stranded RNA viruses vesicular stomatitis virus and Zika virus. Here, we describe methods to propagate and titer these two viruses. We also describe a simple cell-killing assay to begin testing modified viruses for increased potential killing of glioblastoma cells.
Insights
Researchers are exploring viruses like vesicular stomatitis virus and Zika virus as cancer therapies. This study details methods for propagating these viruses and testing their ability to kill glioblastoma cells.
Area of Science:
- Oncolytic virotherapy
- Virology
- Cancer biology
Background:
- Genetic engineering advances enable virus-based cancer treatments.
- Vesicular stomatitis virus (VSV) and Zika virus show promise for oncolysis.
- Targeting cancer cells via viral lysis or immune response is a key strategy.
Purpose of the Study:
- To establish methods for propagating and titering VSV and Zika virus.
- To develop a cell-killing assay for evaluating modified oncolytic viruses.
- To assess the potential of VSV and Zika virus against glioblastoma.
Main Methods:
- Virus propagation techniques for VSV and Zika virus.
- Viral titration assays to determine infectious units.
- Cell-based assays to measure viral-induced glioblastoma cell death.
Main Results:
- Protocols for reliable VSV and Zika virus propagation were established.
- A straightforward cell-killing assay was developed.
- Initial data suggests potential for viral-mediated glioblastoma cell killing.
Conclusions:
- VSV and Zika virus can be effectively propagated and titered.
- The developed assay is suitable for screening oncolytic virus efficacy.
- Further research into modified VSV and Zika virus for glioblastoma treatment is warranted.
Related Concept Videos
Viral Recombination
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Arboviral Encephalitis

